COLOTECT Colorectal Cancer Screening [BGI]*
฿5,690.00
Analyses stool DNA for abnormal methylation of three genes—ADHFE1, PPP2R5C and SDC2—associated with colorectal cancer and advanced precancerous lesions.
Typical Use
Used as a non-invasive screening test for signs associated with colorectal cancer and advanced adenomas. A positive result requires further evaluation, usually colonoscopy. A negative result does not completely exclude colorectal cancer or advanced adenomas.
Preparation
Markers Tested
ADHFE1 methylation
PPP2R5C methylation
SDC2 methylation